🚀 VC round data is live in beta, check it out!
China Re Valuation Multiples
Discover revenue and EBITDA valuation multiples for China Re and similar public comparables like Menora Mivtachim, Medibank, Kinsale Cap Group, AXIS Capital and more.
China Re Overview
About China Re
China Reinsurance (Group) Corp is a Chinese company that is engaged in the reinsurance business. It provides various products and services including reinsurance, direct insurance, asset management, insurance brokerage, and insurance media service. The company offers a variety of reinsurance products for various property and casualty insurance, such as motor, property, agricultural, liability insurance, life, health, accident insurance, and asset management services. It operates through the following business segments: Property and casualty reinsurance, Life and health reinsurance, Primary property and casualty insurance, Asset Management, and Others.
Founded
1949
HQ
Employees
49.0K
Website
Financials (FY)
EV
$9B
China Re Financials
China Re reported last fiscal year revenue of $16B.
In the same fiscal year, China Re generated $2B in net income.
Revenue (LTM)
China Re P&L
In the most recent fiscal year, China Re reported revenue of $16B and net income of $2B.
China Re expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $16B | XXX | XXX | XXX |
| Net Profit | $2B | XXX | $2B | XXX | XXX | XXX |
| Net Margin | — | XXX | 9% | XXX | XXX | XXX |
| Net Debt | — | — | $850M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
China Re Stock Performance
China Re has current market cap of $9B, and enterprise value of $9B.
Market Cap Evolution
China Re's stock price is $0.21.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $9B | $9B | 0.0% | XXX | XXX | XXX | $0.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialChina Re Valuation Multiples
China Re trades at 0.6x EV/Revenue multiple.
EV / Revenue (LTM)
China Re Financial Valuation Multiples
As of March 24, 2026, China Re has market cap of $9B and EV of $9B.
Equity research analysts estimate China Re's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
China Re has a P/E ratio of 5.1x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $9B | XXX | $9B | XXX | XXX | XXX |
| EV (current) | $9B | XXX | $9B | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.6x | XXX | XXX | XXX |
| P/E | 5.1x | XXX | 5.7x | XXX | XXX | XXX |
| EV/FCF | 37.6x | XXX | 6.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified China Re Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
China Re Margins & Growth Rates
China Re's revenue in the last fiscal year declined by (16%).
China Re Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (16%) | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 4% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
China Re Public Comps
See public comps and valuation multiples for other Reinsurance and Insurance Carriers comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Menora Mivtachim | XXX | XXX | XXX | XXX | XXX | XXX |
| Medibank | XXX | XXX | XXX | XXX | XXX | XXX |
| Kinsale Cap Group | XXX | XXX | XXX | XXX | XXX | XXX |
| AXIS Capital | XXX | XXX | XXX | XXX | XXX | XXX |
| Primerica | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
China Re M&A Activity
China Re acquired XXX companies to date.
Last acquisition by China Re was on XXXXXXXX, XXXXX. China Re acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by China Re
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialChina Re Investment Activity
China Re invested in XXX companies to date.
China Re made its latest investment on XXXXXXXX, XXXXX. China Re invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by China Re
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout China Re
| When was China Re founded? | China Re was founded in 1949. |
| Where is China Re headquartered? | China Re is headquartered in China. |
| How many employees does China Re have? | As of today, China Re has over 49K employees. |
| Is China Re publicly listed? | Yes, China Re is a public company listed on HKEX. |
| What is the stock symbol of China Re? | China Re trades under 01508 ticker. |
| When did China Re go public? | China Re went public in 2015. |
| Who are competitors of China Re? | China Re main competitors are Menora Mivtachim, Medibank, Kinsale Cap Group, AXIS Capital. |
| What is the current market cap of China Re? | China Re's current market cap is $9B. |
| What is the current revenue of China Re? | China Re's last fiscal year revenue is $16B. |
| What is the current EV/Revenue multiple of China Re? | Current revenue multiple of China Re is 0.6x. |
| Is China Re profitable? | Yes, China Re is net-income-positive (as of the last 12 months). |
| What is the current net income of China Re? | China Re's last 12 months net income is $2B. |
| What is the current FCF of China Re? | China Re's last 12 months FCF is $239M. |
| What is the current EV/FCF multiple of China Re? | Current FCF multiple of China Re is 37.6x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.